((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Joining us is the company Sanofi and Regeneron to talk to us more about COPD also known as Chronic Obstructive Pulmonary ...

Dupixent approved in China as the first-ever biologic medicine for patients with chronic obstructive pulmonary disease (COPD). September 27, 2024. Accessed September 27, 2024.

Dupixent is an “add-on” drug for COPD, meaning patients take it in addition to inhaled medication Dupixent isn’t approved as a stand-alone treatment for COPD. The U.S. Food and Drug ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an ...

Dr MeiLan Han, a Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan Health, discusses the impact inadequately controlled COPD has on daily ...

Personalized Medicine. 2014;11(7):669-679. In this article, we will describe the current status of personalized medicine for chronic, complex diseases using chronic obstructive pulmonary disease ...

Opens in a new tab or window “Compared to non-CMR recipients, CMR recipients experienced a considerably higher increase in adherence to COPD medications from 2016 to 2017, and findings with data ...

Dupixent approved in China as the first-ever biologic medicine for patients with COPD Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on ...

Dupixent for the treatment of COPD has been approved in more than 30 countries worldwide, including the 27 countries in the EU. Professor Kang Jian Chair of COPD Branch, Chinese Association of ...